title: Durable complete remission induced by cetuximab monotherapy in a patient infected with HIV and diagnosed with recurrent squamous cell carcinoma of the head and neck.
authors.affiliation: John H. Stroger Jr. Hospital of Cook County, Chicago, IL, USA.
authors.forename: Paul G
authors.initials: PG
authors.lastname: Rubinstein
authors.forename: Valerie
authors.initials: V
authors.lastname: Lindgren
authors.forename: Suman
authors.initials: S
authors.lastname: Setty
authors.forename: Mike
authors.initials: M
authors.lastname: Yao
authors.forename: Kristen B
authors.initials: KB
authors.lastname: Pytynia
authors.forename: James A
authors.initials: JA
authors.lastname: Radosevich
authors.forename: ShriHari S
authors.initials: SS
authors.lastname: Kadkol
authors.forename: Lawrence E
authors.initials: LE
authors.lastname: Feldman
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000188:drug therapy* / Q000821:virology; D000068818:Cetuximab; D005260:Female; D006678:HIV / Q000472:pathogenicity*; D015658:HIV Infections / Q000150:complications* / Q000821:virology; D006258:Head and Neck Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000188:drug therapy* / Q000821:virology; D012074:Remission Induction; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab